Skip to main content
Close
Home
Society of Hospital Medicine
Presented by Society of Hospital Medicine
Home
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Randy Dotinga

News

Monoclonal antibodies for COVID – Give IV infusion or an injection?

Author:
Randy Dotinga
Publish date: April 14, 2022

There are many benefits to subcutaneous administration versus IV.

  • Read More

News

Analysis boosts fluvoxamine for COVID, but what’s the evidence?

Author:
Randy Dotinga
Publish date: April 11, 2022

“I’m not sure how useful this is given we have several antiviral agents available. Why would we choose this over Paxlovid, remdesivir, or...

  • Read More

News

First-line CAR T-cell therapy could help cure some lymphomas

Author:
Randy Dotinga
Publish date: March 22, 2022

Axi-cel is already approved for some forms of relapsed/refractory lymphoma, and a new phase 2 study hints that it has potential as a frontline...

  • Read More

News

COVID-19–alopecia areata link? Review doesn’t find much evidence

Author:
Randy Dotinga
Publish date: March 18, 2022

Few reports have connected the two conditions.

  • Read More

News

Hemophilia: There’s a new app for that

Author:
Randy Dotinga
Publish date: March 16, 2022

Researchers consulted patients and caregivers to develop a tool designed to track progress.

  • Read More

News

Updated perioperative guidance says when to hold antirheumatics

Author:
Randy Dotinga
Publish date: March 4, 2022

Rheumatologists and orthopedic surgeons revise advice on JAK inhibitors and add new medications.

  • Read More

News

Analysis questions tocilizumab in ventilated COVID patients

Author:
Randy Dotinga
Publish date: March 3, 2022

Statistical review of earlier meta-analysis supports use of arthritis drug in hospitalized patients on non-invasive respiration.

  • Read More

News

Researchers tout new CLL prognostic tool

Author:
Randy Dotinga
Publish date: February 23, 2022

CLL-CI relies on comorbidity scoring to predict levels of risk linked to survival, time to treatment.

  • Read More

News

Gene therapy: A ‘one and done’ hemophilia B treatment?

Author:
Randy Dotinga
Publish date: February 17, 2022

Phase 3 study of a one-time gene therapy shot enabled almost all hemophilia B patients to end full-dose bleeding prophylaxis.

  • Read More

News

OTC melatonin supplement use rises fivefold over 20 years

Author:
Randy Dotinga
Publish date: February 2, 2022

The study was designed to evaluate the breadth of use of melatonin, rather than its effectiveness as a sleep aid.

  • Read More

News

Hormone therapy in transgender teens linked to better adult mental health

Author:
Randy Dotinga
Publish date: January 24, 2022

But study is based on a survey with limitations, and other outcomes didn’t improve.

  • Read More

News

Symptoms common in high-risk, early-stage ovarian cancer

Author:
Randy Dotinga
Publish date: January 12, 2022

More than 70% had at least one symptom such as abdominal/pelvic pain or increased girth/fullness.

  • Read More

News

Augmented autism screening pays big dividends

Author:
Randy Dotinga
Publish date: January 11, 2022

New strategy boosts diagnoses in boys and Spanish speakers, study finds.

  • Read More

News

Palliative care specialists seek greater role in lung disease

Author:
Randy Dotinga
Publish date: January 10, 2022

Few pulmonology patients use the services, but experts say the benefit is immense.

  • Read More

News

Even healthy Black and Hispanic women have more cesareans than White women

Author:
Randy Dotinga
Publish date: January 4, 2022

It’s not clear why disparity exists, but it’s not because their deliveries are riskier.

  • Read More

Pages

  • « first
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »
An Official Publication of the Society of Hospital Medicine

Society of Hospital Medicine
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Copyright  © 2022 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Menu Close